POZ October-November 2016

POZ October-November 2016

In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.

Also Available On:



In the Spotlight: Hamilton’s Javier Munoz

After taking center stage in “Hamilton,” Javier Muñoz reflects on his HIV journey.

Runway Realness: Front Row at GMHC’s Latex Ball

Front row at GMHC’s Latex Ball

Decision 2016: The Politics of a Pandemic

National, state and local races will affect HIV prevention, care and treatment—both at home and abroad.

Party Platforms and Candidate Positions

Evaluate HIV-related issues in the 2016 election.

HIV-Positive Politicians and HIV Advocates

HIV-related insights on the 2016 election.

From the Editor

Oriol R. Gutierrez

This Land is Your Land

Much is at stake in this election. The results up and down the ballot will directly affect HIV prevention, care and treatment.


Faith in Healing

UMMA Community Clinic marks 20 years serving the Muslim and Latino communities of South Los Angeles.

POZ Planet

Brotherly Love

Daniel D. Driffin speaks about HIV at the DNC.

Meet A Very, Very Long-Term Survivor

Elleder and his team reconstructed ancient viral genomes, dating the oldest lentiviruses to as long ago as 60 million years.

Law-Fighting Citizens

A new movement to update laws that criminalize HIV

Mercy, Faith & Relaxation

A group for HIV-positive Muslims holds its first retreat.


A video campaign gives voice to trans women and HIV.

Poz Stories: Billy Duckett

“To prevent HIV, we need more outreach,” Duckett says. “I would have never gotten sick had I gotten tested and treated.

Dating Apps & the “Digital Quarantine”

POZ readers weigh in on the option of filtering by HIV status on the gay dating app Grindr.

When Undetectable…

Spreading the word about the “negligible risk” of transmitting HIV


After Pulse

Cecilia Aldarondo—a native of Orlando and the director of Memories of a Penitent Heart—reflects on the sanctuary of gay clubs.



A peek at some of the social media buzz.

Care and Treatment

ARVs Nearly Halt Breast-Feeding Transmission

HIV-positive breast-feeding mothers can nearly eliminate the risk of transmitting HIV to their babies by taking ARVs.

The War on Drugs Fuels the Spread of Diseases

Mass imprisonment of drug users worldwide, as well as a scarcity of harm reduction programs, contributes to the spread of HIV.

Undetectable = No Transmission

The HPTN 052 trial found no transmissions between mixed-HIV-status heterosexual couples when the HIV-positive partner was undetectable.

Still No New Transmissions in PARTNER Trial

New findings from the PARTNER trial saw no transmissions within the couples, underlining the power of ARVs to curb the spread of HIV.

Research Notes

Prevention: Vaginal Ring

Women who used the monthly ring at high levels benefited from a significant HIV risk reduction.

Treatment: Monthly Dosing

A long-acting injectable HIV regimen dosed every four weeks is slated to advance to Phase III trials in late 2016.

Concerns: PEPFAR Funding

The U.S. President’s Emergency Plan for AIDS Relief gives aid disproportionately to countries with epidemics generalized across risk groups.

Cure: Cure Collective

Scientists have created a consortium to help them better understand and potentially achieve a cure based on stem cell transplants.

POZ Survey Says

Facing Discrimination

HIV-related discrimination is among the top barriers to HIV prevention, treatment, care and support. Here are your responses to our survey.

POZ Heroes

Found in Translation

Through educating herself about HIV, Arianna Lint learned to shed the self-stigma she felt and became determined to live out loud.


Hot topics

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy


POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.